Cornercap Investment Counsel Inc Monte Rosa Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $329 Million
- Q3 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 19,236 shares of GLUE stock, worth $163,313. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,236
Previous 41,917
54.11%
Holding current value
$163,313
Previous $156,000
35.26%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding GLUE
# of Institutions
83Shares Held
43.9MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$65.3 Million3.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$56 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.79MShares$49.2 Million0.46% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$41.7 Million0.28% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.66MShares$22.6 Million0.55% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $397M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...